Cell-Targeted Inhibition of CaMK4 Suppresses Tertiary Lymphoid-like Structure Development in Lupus-Prone Mice

Area of Science:

• Immunology
• Nephrology
• Molecular Biology

Background:

• Current lupus nephritis (LN) treatments use broad immunosuppression, often failing to eliminate inflammation-driving intrarenal immune niches.
• Tertiary lymphoid structures (TLS) are key drivers of local immune activation and tissue injury in LN.

Purpose of the Study:

• To investigate the role of Calcium calmodulin kinase IV (CaMK4) in regulating renal TLS-like organization in lupus nephritis.
• To evaluate the efficacy of CaMK4 inhibition, particularly through targeted delivery, in suppressing TLS formation and associated inflammation.

Main Methods:

• Utilized CaMK4-deficient MRL/lpr mice and KN93-loaded nanoparticles targeted to CD4+ T cells or podocytes.
• Quantified TLS-associated inflammation and maturation markers (CD3, CD20, Ki67, α-SMA) via fluorescence intensity.
• Compared results with vehicle-treated controls.

Main Results:

• CaMK4 inhibition, both genetic and pharmacologic, reduced TLS-associated inflammation markers.
• Uniform suppression of CD20 signal indicated a critical role for B cells in TLS maintenance.
• Podocyte-targeted KN93 demonstrated the strongest suppression of TLS-like formation, implicating podocyte pathways.

Conclusions:

• CaMK4 is identified as a regulator of TLS architecture in lupus nephritis.
• Cell-targeted CaMK4 inhibition shows translational potential for disrupting local immune recruitment in LN.
• Targeting podocyte-specific CaMK4 pathways may offer a novel therapeutic strategy with reduced systemic toxicity.